Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01564251
Title A Study of GDC-0575 Alone And in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
The Sarah Cannon Research Inst Nashville Tennessee 37203 United States Details
Institut Bergonie; Oncologie Bordeaux 33076 France Details
Institut Gustave Roussy; Departement Oncologie Medicale Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field